In the last four decades, advancements in technologies to copy, measure, and manipulate DNA and RNA in situ have enabled new methods for research and diagnosis of disease. As a subset of these methods, novel microfluidic platforms have emerged that have demonstrated assay that can run at lower-cost, have lower-sample ...